Navigation Links
Hyperion Therapeutics Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of GT4P in Patients With Urea Cycle Disorders
Date:10/23/2007

SOUTH SAN FRANCISCO, Calif., Oct. 23 /PRNewswire/ -- Hyperion Therapeutics, Inc. today announced that the first patient has been enrolled in a Phase 1/2 clinical trial of Glyceryl Tri (4-Phenylbutyrate) (GT4P) in patients with urea cycle disorders (UCDs).

(Logo: http://www.newscom.com/cgi-bin/prnh/20070905/AQW076LOGO)

"UCDs are complex disorders which require a multi-faceted management approach, including a protein restricted diet, amino acid supplementation, and pharmacological therapy," said Brendan Lee, M.D., Ph.D. the first investigator to enroll a patient in the GT4P Phase 1/2 trial and Professor, Department of Molecular and Human Genetics at Baylor College of Medicine. "We look forward to seeing the results from the clinical trials of GT4P in the management of UCDs."

The phase 1/2 study is designed to evaluate the safety, tolerability and ammonia scavenging effects of GT4P compared to BUPHENYL(R) (sodium phenylbutyrate) in patients with UCDs. A total of up to ten adults with stable UCD will be included in the trial, which is being conducted at US-based clinical sites. Estimated duration of treatment is 3 to 4 weeks.

"We are very excited about our research of GT4P focused on the chronic management of urea cycle disorders," said Marvin Garovoy, Senior Vice President of Clinical Development of Hyperion Therapeutics, Inc. "Initiation of this trial marks the beginning of several Hyperion clinical programs aimed at developing new therapies for hepatic disease."

About GT4P

GT4P is composed of a glycerol backbone covalently attached via ester linkages to three molecules of phenylbutyrate. It is a prodrug of BUPHENYL(R) (a currently FDA-approved adjunctive therapy in the chronic management of patients with urea cycle disorders involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic aci
'/>"/>

SOURCE Hyperion Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 WuXi PharmaTech (Cayman) ... technology platform company serving the pharmaceutical, biotechnology, and medical ... and the United States , ... designation from the U.S. FDA for ibalizumab (TMB355). The ... it is intended, alone or in combination with one ...
(Date:2/27/2015)... TEL-AVIV , Israele, February 27, 2015 /PRNewswire/ ... continua nel suo sviluppo dell,innovativo sistema di monitoraggio ... il primo trial sull,uomo-   ... operante nello sviluppo di nuovo sistema per il ... congestizio (CHF), ha annunciato oggi di aver concluso ...
(Date:2/27/2015)... , Feb. 27, 2015  Boston Scientific Corporation ... in the Barclays 2015 Annual Healthcare Conference on March ... Dan Brennan , executive vice president and ... president, Investor Relations, will participate in a 25-minute question ... analyst at approximately 1:05 p.m. ET. Following a 5-minute ...
Breaking Medicine Technology:WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2
... DALLAS, April 15, 2011 IntelliCentrics, Inc., owner and ... acquisition of Status Blue, LLC, a leading vendor compliance ... will unite the majority of the industry,s credentialing efforts ... IntelliCentrics a history of outstanding customer care and grounded ...
... Idaho and DANA POINT, Calif., April 15, 2011 ... and manufacturing nutritional supplements, today announced the establishment ... Resources (IHR), a renowned provider of medical information, ... wellness and health promotion, and integrative care. Health ...
Cached Medicine Technology:IntelliCentrics, Inc. Acquires Hospital Vendor Credentialing Solution Status Blue, LLC 2IntelliCentrics, Inc. Acquires Hospital Vendor Credentialing Solution Status Blue, LLC 3Thorne Research and Integrative Health Resources Establish Joint Venture to Provide Full Range of Services in Practice Development, Patient and Clinician Education, and Access to Nutritional Supplements in Integrative Medicine 2Thorne Research and Integrative Health Resources Establish Joint Venture to Provide Full Range of Services in Practice Development, Patient and Clinician Education, and Access to Nutritional Supplements in Integrative Medicine 3Thorne Research and Integrative Health Resources Establish Joint Venture to Provide Full Range of Services in Practice Development, Patient and Clinician Education, and Access to Nutritional Supplements in Integrative Medicine 4
(Date:2/27/2015)... FACE Skincare~Medical~Wellness, a multiaward-winning leader ... unique combination to take fifteen years off of ... a new treatment introduced that is the first ... to improve lines and wrinkles on the Décolleté. ... suffers from the stubborn vertical lines between the ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Mediaplanet today ... “Blood Health,” a campaign that aims to bring blood ... health care conversation. The stories in this edition go ... world of clinical care, hard-hitting advocacy, research and technological ... , According the American Cancer Society, approximately every ...
(Date:2/27/2015)... 27, 2015 Glidewell Laboratories, industry-leading ... launch of its CloudPoint™ family of ... production of monolithic zirconia crowns & bridges, CloudPoint ... providing the CAD/CAM-produced restorations that doctors demand. Installation ... which cases can be scanned, managed and produced. ...
(Date:2/27/2015)... February 27, 2015 Healthpointe is ... suffered from injuries or diseases affecting the ... physicians are located throughout Southern California, and are ... to treat conditions related to the upper extremities. ... M. Ashley are board-certified and fully trained in ...
(Date:2/27/2015)... CHICAGO, IL (PRWEB) February 27, 2015 ... start-up Output Medical to advance the development of ... commercialization. The new solution is being developed in ... that offer only 73% accuracy and error margins ... will automate error-free output measurement and provide trending ...
Breaking Medicine News(10 mins):Health News:Face Skincare Announces New Combination Therapy 2Health News:Know Your Blood: Raising Awareness through Mediaplanet’s “Blood Health” Campaign 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 3Health News:Healthpointe is Now Performing Arthroscopic Surgery Techniques for Elbow, Hand and Wrist Injuries and Diseases, such as certain Ganglion Cysts 2Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3
... Third ... ... Sacha Obaid, North Texas plastic and craniofacial surgeon , www.northtexasplasticsurgery.com announced ... at Cook Children,s Medical Center in Fort Worth. JT was born with an ...
... ... be focusing on the importance of family communications and promoting the value of open and ... ... should be top priority for parents this holiday season, according to Robert Moore, CEO of ...
... of after, clearly improves treatment of women with HER2+ breast ... a Mayo Clinic researcher who led what is regarded to ... Herceptin. Patients using Herceptin and chemotherapy at the ... risk of recurrence of cancer or death, compared with women ...
... , ... cosmetic dentist in Odessa, Texas , is participating in the popular Toys for Tots ... toys for the holidays. Donors at Dr. Rutherford’s practice are also entered into a drawing ... ...
... ... sales over the previous year. The increase is probably due to the giant tide of ... believes that LogoLoft.com is providing Americans with a valuable service during these hard economic times. ... Montgomery, Alabama (PRWEB) December ...
... DALLAS, Dec. 11 Baylor Health Care System,s website ... thirteenth annual Healthcare Internet Conference and silver at this ... awards program recognizes the best websites of healthcare organizations, ... and business improvement initiatives. More than 1,100 entries were ...
Cached Medicine News:Health News:Surgeons Create Palate for Baby with Rare Facial Abnormality 2Health News:This Holiday Season Give Your Children the Gift that Saves Lives: Safer Sex 2Health News:Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy 2Health News:Odessa Texas Cosmetic Dentist Sponsoring Marine Toys for Tots Program to Give Children in Need Free Toys for the Holidays 2Health News:Odessa Texas Cosmetic Dentist Sponsoring Marine Toys for Tots Program to Give Children in Need Free Toys for the Holidays 3Health News:LogoLoft.com Posts 64% Sales Increase Over Previous Year As More Americans Start Their Own Businesses 2Health News:BaylorHealth.com Wins National Healthcare Website Awards 2
Console Horizontal Airflow Cabinet...
... chemical fumes, allowing safe indoor ... filters remove most organic contaminants. ... flow speed = 100 fpm ... air speed monitor, quick-release filter/blower ...
... fume hood ventilates and purifies ... release of exhaust. Bonded charcoal ... Configurations are available with vertical ... final HEPA filter, work bench ...
... polypropylene exhaust hoods are designed to rest ... draw a stream of air across the ... operator. Other sizes and types of hoods ... are available on special order in materials ...
Medicine Products: